Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000104

Chief Financial Officer sold 2,490 shares at $20.67 ($51,463)

  • Chief Financial Officer acquired 8,636 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

van Houte Hans · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-07-30 Exercise or conversion : show line 1 in the form +2,886 51,219 D
2024-07-30 Exercise or conversion : show line 2 in the form +2,000 53,219 D
2024-07-30 Exercise or conversion : show line 3 in the form +3,750 56,969 D
2024-07-30 Sale : show line 4 in the form −2,490 $20.67 $51,463 54,479 D
Open-market sales · 2,490 sh · avg $20.67 · $51,463

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-07-30 Exercise or conversion : show line 5 in the form Restricted Stock Units −2,886 17,317 D
2024-07-30 Exercise or conversion : show line 6 in the form Restricted Stock Units −2,000 14,000 D
2024-07-30 Exercise or conversion : show line 7 in the form Restricted Stock Units −3,750 41,250 D
Loading xslF345X05/wk-form4_1722380754.xml…